Form 4 for TARS Tarsus Pharmaceuticals, Inc.

Accepted 2026-06-16 16:05:57 ET · period of report 2026-06-12 · accession 0002044770-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-06-16 16:05	2026-06-12	TARS	Goodrich Katherine	Dir	M - OptEx	—	+2,954	5,187	+132%	—
D	2026-06-16 16:05	2026-06-12	TARS	Goodrich Katherine	Dir	M - OptEx	$0.00	-2,954	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-12	M	A	2,954	—	5,187	D	—	—	(F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
2	Derivative	Restricted Stock Units	2026-06-12	M	D	2,954	$0.00	0	D	— · — to —	2,954 Common Stock	(F2) Each RSU represents a contingent right to receive one share of the Company's common stock. (F3) RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. (F3) RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.